The Food and Drug Administration's approval the use of Wegovy for reducing risk of heart attack and stroke could allow approximately 3.6 million Medicare recipients to gain access to the popular weight-loss drug, according to a new analysis.
The FDA recently approved a new use for Wegovy, the blockbuster anti-obesity drug, to reduce the risk of heart attacks and stroke in people with cardiovascular disease who are overweight or obese - a decision that opens the door to Medicare coverage of Wegovy, which is prohibited by law from coverin…
